S100A11, an dual mediator for growth regulation of human keratinocytes

Molecular Biology of the Cell

Volumn 19, Issue 1, 2008, Pages 78-85

  Sakaguchi, Masakiyo ^a   Sonegawa, Hiroyuki ^a   Murata, Hitoshi ^a,b   Kitazoe, Midori ^b   Futami, Jun Ichiro ^b   Kataoka, Ken ^a   Yamada, Hidenori ^b   Huh, Nam Ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; EPIDERMAL GROWTH FACTOR; PROTEIN S 100; PROTEIN S 100 A 11; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; KERATINOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 38749092048     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-07-0682     Document Type: Article

References (56)

1. Adami, C., Sorci, G., Blasi, E., Agneletti, A. L., Bistoni, F., and Donato, R. (2001). S100B expression in and effects on microglia. Glia 33, 131-142.
2. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., and Hemmings, B. A. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551.
3. Arumugam, T., Simeone, D. M., Schmidt, A. M., and Logsdon, C. D. (2004). S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 279, 5059-5065.
4. Arumugam, T., Simeone, D. M., Van Golen, K., and Logsdon, C. D. (2005). S100P promotes pancreatic cancer growth, survival, and invasion. Clin. Cancer Res. 11, 5356-5364.
5. Bogumil, T., Rieckmann, P., Kubuschok, B., Felgenhauer, K., and Bruck, W. (1998). Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci. Lett. 247, 195-197.
6. Cecil, D. L., Johnson, K., Rediske, J., Lotz, M., Schmidt, A. M., and Terkeltaub, R. (2005). Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 175, 8296-8302.
7. Crnogorac-Jurcevic, T., Missiaglia, E., Blaveri, E., Gangeswaran, R., Jones, M., Terris, B., Costello, E., Neoptolemos, J. P., and Lemoine, N. R. (2003). Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J. Pathol. 201, 63-74.
8. Dempsey, A. C., Walsh, M. P., and Shaw, G. S. (2003). Unmasking the annexin I interaction from the structure of Apo-S100A11. Structure 11, 887-897.
9. Donato, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668.
10. Donato, R. (2003). Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60, 540-551.
11. Du, K., and Montminy, M. (1998). CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377-32379.
12. Ehlermann, P., Eggers, K., Bierhaus, A., Most, P., Weichenhan, D., Greten, J., Nawroth, P. P., Katus, H. A., and Remppis, A. (2006). Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc. Diabetol. 5, 6.
13. Emberley, E. D., Murphy, L. C., and Watson, P. H. (2004). S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell Biol. 82, 508-515.
14. Foell, D., Frosch, M., Sorg, C., and Roth, J. (2004). Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta 344, 37-51.
15. Foulstone, E. J., Tavare, J. M., and Gunn-Moore, F. J. (1999). Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells. Neurosci. Lett. 264, 125-128.
16. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. (1993). Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 4, 121-133.
17. Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K., and Massague, J. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446, 765-770.
18. Heizmann, C. W., Fritz, G., and Schafer, B. W. (2002). S100 proteins: structure, functions and pathology. Front. Biosci. 7, d1356-d1368.
19. Hofmann, M. A. et al. (1999). RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901.
20. Hori, O. et al. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite out-growth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
21. Hsieh, H. L., Schafer, B. W., Weigle, B., and Heizmann, C. W. (2004). S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem. Biophys. Res. Commun. 316, 949-959.
22. Huttunen, H. J., Fages, C., and Rauvala, H. (1999). Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
23. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., and Rauvala, H. (2000). Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
24. Ji, J., Zhao, L., Wang, X., Zhou, C., Ding, F., Su, L., Zhang, C., Mao, X., Wu, M., and Liu, Z. (2004). Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 130, 480-486.
25. Kanamori, T. et al. (2004). Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol. Hum. Reprod. 10, 735-742.
26. Kuruto, R., Nozawa, R., Takeishi, K., Arai, K., Yokota, T., and Takasaki, Y. (1990). Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J. Biochem. 108, 650-653.
27. Landriscina, M., Soldi, R., Bagala, C., Micucci, I., Bellum, S., Tarantini, F., Prudovsky, I., and Maciag, T. (2001). S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J. Biol. Chem. 276, 22544-22552.
28. Liao, H. et al. (2004). Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis. Rheum. 50, 3792-3803.
29. Lugering, N., Stoll, R., Kucharzik, T., Schmid, K. W., Rohlmann, G., Burmeister, G., Sorg, C., and Domschke, W. (1995). Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 56, 406-414.
30. Mailliard, W. S., Haigler, H. T., and Schlaepfer, D. D. (1996). Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J. Biol. Chem. 271, 719-725.
31. Marenholz, I., Heizmann, C. W., and Fritz, G. (2004). S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322, 1111-1122.
32. Moroz, O. V. et al. (2002). The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. D. Biol. Crystallogr. 58, 407-413.
33. Nickel, W. (2005). Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 6, 607-614.
34. Ohuchida, K., Mizumoto, K., Ohhashi, S., Yamaguchi, H., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., and Tanaka, M. (2006). S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin. Cancer Res. 12, 5417-5422.
35. Oue, N., Hamai, Y., Mitani, Y., Matsumura, S., Oshimo, Y., Aung, P. P., Kuraoka, K., Nakayama, H., and Yasui, W. (2004). Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 64, 2397-2405.
36. Prudovsky, I., Bagala, C., Tarantini, F., Mandinova, A., Soldi, R., Bellum, S., and Maciag, T. (2002). The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J. Cell Biol. 158, 201-208.
37. Rety, S., Osterloh, D., Arie, J. P., Tabaries, S., Seeman, J., Russo-Marie, F., Gerke, V., and Lewit-Bentley, A. (2000). Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure 8, 175-184.
38. Roth, J., Vogl, T., Sorg, C., and Sunderkotter, C. (2003). Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155-158.
39. Rothermundt, M., Peters, M., Prehn, J. H., and Arolt, V. (2003). S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60, 614-632.
40. Ryckman, C., Vandal, K., Rouleau, P., Talbot, M., and Tessier, P. A. (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170, 3233-3242.
41. Sakaguchi, M., Miyazaki, M., Inoue, Y., Tsuji, T., Kouchi, H., Tanaka, T., Yamada, H., and Namba, M. (2000). Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J. Cell Biol. 149, 1193-1206.
42. Sakaguchi, M., Miyazaki, M., Takaishi, M., Sakaguchi, Y., Makino, E., Kataoka, N., Yamada, H., Namba, M., and Huh, N. H. (2003). S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J. Cell Biol. 163, 825-835.
43. Sakaguchi, M., Miyazaki, M., Sonegawa, H., Kashiwagi, M., Ohba, M., Kuroki, T., Namba, M., and Huh, N. H. (2004). PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J. Cell Biol. 164, 979-984.
44. Sakaguchi, M., Sonegawa, H., Nukui, T., Sakaguchi, Y., Miyazaki, M., Namba, M., and Huh, N. H. (2005). Bifurcated converging pathways for high Ca2+-and TGFbeta-induced inhibition of growth of normal human keratinocytes. Proc. Natl. Acad. Sci. USA 102, 13921-13926.
45. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., and Scarborough, G. A. (1992). Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267, 4854-4858.
46. Sato, N., Fukushima, N., Matsubayashi, H., and Goggins, M. (2004). Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23, 1531-1538.
47. Schaefer, K. L. et al. (2004). Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Res. 64, 3395-3405.
48. Schmidt, A. M. et al. (1992). Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997.
49. Stulik, J., Koupilova, K., Osterreicher, J., Knizek, J., Macela, A., Bures, J., Jandik, P., Langr, F., Dedic, K., and Jungblut, P. R. (1999). Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20, 3638-3646.
50. Tanaka, M., Adzuma, K., Iwami, M., Yoshimoto, K., Monden, Y., and Itakura, M. (1995). Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. Cancer Lett. 89, 195-200.
51. Todoroki, H., Kobayashi, R., Watanabe, M., Minami, H., and Hidaka, H. (1991). Purification, characterization, and partial sequence analysis of a newly identified EF-hand type 13-kDa Ca(2+)-binding protein from smooth muscle and non-muscle tissues. J. Biol. Chem. 266, 18668-18673.
52. Torres-Cabala, C., Panizo-Santos, A., Krutzsch, H. C., Barazi, H., Namba, M., Sakaguchi, M., Roberts, D. D., and Merino, M. J. (2004). Differential expression of S100C in thyroid lesions. Int. J. Surg. Pathol. 12, 107-115.
53. Tsai, J. C., Goldman, C. K., and Gillespie, G. Y. (1995). Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 82, 864-873.
54. Wu, J., Smith, L. T., Plass, C., and Huang, T. H. (2006). ChIP-chip comes of age for genome-wide functional analysis. Cancer Res. 66, 6899-6902.
55. Xu, D., and Kyriakis, J. M. (2003). Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J. Biol. Chem. 278, 39349-39355.
56. Yan, S. D. et al. (1996). RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.